ASCL2 and gastric cancer: The ASCL2 shows a negative correlation with H. pylori-induced gastrointestinal inflammation, uses resistin as a regulator of inflammation, activates TLR signaling and TLR4 cascade, and positively correlates with gastric cancer by GSEA (Fig. 5C, D).